White, Brian S. https://orcid.org/0000-0002-2954-4410
de Reyniès, Aurélien
Newman, Aaron M. https://orcid.org/0000-0002-1857-8172
Waterfall, Joshua J. https://orcid.org/0000-0002-3762-5050
Lamb, Andrew
Petitprez, Florent https://orcid.org/0000-0002-5117-6466
Lin, Yating https://orcid.org/0000-0001-5061-5132
Yu, Rongshan https://orcid.org/0000-0003-2179-173X
Guerrero-Gimenez, Martin E.
Domanskyi, Sergii
Monaco, Gianni https://orcid.org/0000-0002-7863-4068
Chung, Verena https://orcid.org/0000-0002-5622-7998
Banerjee, Jineta https://orcid.org/0000-0002-1775-3645
Derrick, Daniel https://orcid.org/0000-0003-3305-3507
Valdeolivas, Alberto
Li, Haojun
Xiao, Xu https://orcid.org/0000-0003-3743-3582
Wang, Shun https://orcid.org/0000-0003-1592-9587
Zheng, Frank
Yang, Wenxian https://orcid.org/0000-0002-5349-9680
Catania, Carlos A.
Lang, Benjamin J. https://orcid.org/0000-0002-2205-8591
Bertus, Thomas J.
Piermarocchi, Carlo
Caruso, Francesca P. https://orcid.org/0000-0002-2206-1459
Ceccarelli, Michele https://orcid.org/0000-0002-4702-6617
Yu, Thomas
Guo, Xindi
Bletz, Julie
Coller, John
Maecker, Holden https://orcid.org/0000-0003-0795-9946
Duault, Caroline https://orcid.org/0000-0003-2742-1668
Shokoohi, Vida
Patel, Shailja
Liliental, Joanna E.
Simon, Stockard
,
de Reyniès, Aurélien
Jain, Aashi
Mishra, Shreya
Kumar, Vibhor
Peng, Jiajie
Han, Lu
Otazu, Gonzalo H.
Meadows, Austin
Danaher, Patrick J.
Jaakkola, Maria K.
Elo, Laura L.
Racle, Julien
Gfeller, David
Livne, Dani
Efroni, Sol
Snir, Tom
Cast, Oliver M.
Miller, Martin L.
Couturier, Dominique-Laurent
Chang, Wennan
Cao, Sha
Zhang, Chi
Otto, Dominik J.
Reiche, Kristin
Kämpf, Christoph
Rade, Michael
Schimmelpfennig, Carolin
Kreuz, Markus
Scholz, Alexander
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Heiser, Laura M. https://orcid.org/0000-0003-3330-0950
Guinney, Justin
Gentles, Andrew J. https://orcid.org/0000-0002-0941-9858
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA209971, CA209923, CA209971, CA209923, CA209923, CA209923, CA209988, CA209923)
U.S. Department of Health & Human Services | National Institutes of Health (U24CA224309, R01GM122085, R01GM122085, R01GM122085, U24CA224309, U24CA224309)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
A.d.R was supported by the Programme Cartes d’Identité des Tumeurs (CIT) from the Ligue Nationale Contre le Cancer
U.S. Department of Health & Human Services | NIH | National Cancer Institute
J.J.W. was supported by the SiRIC-Curie program
U.S. Department of Health & Human Services | NIH | National Cancer Institute
F.P. was supported by the Programme Cartes d’Identité des Tumeurs (CIT) from the Ligue Nationale Contre le Cancer
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 28 August 2023
Accepted: 11 July 2024
First Online: 27 August 2024
Change Date: 12 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-53843-9
Competing interests
: A.M.N. is a co-founder of CiberMed, Inc., and A.J.G. has consulted for CiberMed, Inc. J.S.R. received funding from GlaxoSmithKline and Sanofi and consultant fees from Travere Therapeutics and Astex Therapeutic. A.V. is currently employed by F. Hoffmann-La Roche Ltd. The remaining authors declare no competing interests.